Marcadores
follow-up
evaluation of response
staging
ovarian cancer
nuclear medicine
pet/ct
alpha particles
radium223
radionuclide therapies
painful bone metastasis
prostate cancer
immuno therapy side effects
pet/ct and immunotherapy
true progressive disease versus immune stimulation
imaging and immune response evaluation to therapy
imunotherapy
Ver mais
Apresentações
(3)Marcadores
follow-up
evaluation of response
staging
ovarian cancer
nuclear medicine
pet/ct
alpha particles
radium223
radionuclide therapies
painful bone metastasis
prostate cancer
immuno therapy side effects
pet/ct and immunotherapy
true progressive disease versus immune stimulation
imaging and immune response evaluation to therapy
imunotherapy
Ver mais